Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus
Clinical trial NCT06719024 · RECRUITING
Trial details
- NCT number
- NCT06719024
- Sponsor
- Hospital Authority, Hong Kong
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-29
- Primary completion
- 2025-06-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.